High-dose chemotherapy with bone marrow rescue for high-grade gliomas in adults

Cancer Investigation

Volumn 19, Issue 1, 2001, Pages 41-48

  Brandes, A A ^a   Palmisano, V ^a   Pasetto, L M ^a   Basso, U ^a   Monfardini, S ^a  

^a UNIVERSITY HOSPITAL OF PADOVA   (Italy)

Author keywords

Adults; High dose chemotherapy; High grade gliomas; Review

Indexed keywords

ADJUVANT THERAPY; ADULT; ARTICLE; AUTOLOGOUS BONE MARROW TRANSPLANTATION; CANCER CHEMOTHERAPY; CANCER GRADING; CANCER RECURRENCE; CANCER SURVIVAL; CLINICAL ARTICLE; CLINICAL TRIAL; DISEASE ASSOCIATION; DOSE RESPONSE; GLIOMA; GRANULOCYTE; HUMAN; PHASE 2 CLINICAL TRIAL; PNEUMOCYSTIS CARINII; PRIORITY JOURNAL; PROGNOSIS; SOLID TUMOR;

ADULT; ANTINEOPLASTIC AGENTS; BONE MARROW TRANSPLANTATION; BRAIN NEOPLASMS; CARMUSTINE; CHEMOTHERAPY, ADJUVANT; COMBINED MODALITY THERAPY; GLIOMA; HUMANS; NEOPLASM RECURRENCE, LOCAL; TRANSPLANTATION, AUTOLOGOUS;

EID: 0035087923     PISSN: 07357907     EISSN: None     Source Type: Journal    
DOI: 10.1081/CNV-100000084     Document Type: Article

References (24)

1. Medical treatment in high grade malignant gliomas in adults: An overview
2. The importance of dose intensity in the outcome of chemotherapy
3. Dose: Critical factor in cancer chemotherapy
4. Evoluzione del concetto di dose in chemioterapia: Basi teoriche e modelli matematici
5. Nitrosoureas: A review of experimental antitumor activity
6. Variations in response of human brain tumors to BCNU in vitro
7. The role of autologous stem cell reconstitution in intensive therapy for resistant neoplasm
8. Prolongation of survival for high-grade malignant gliomas with adjuvant high-dose BCNU and autologous bone marrow transplantation
9. High dose BCNU chemotherapy with autologous bone marrow transplantation and full dose radiotherapy for grade IV astrocytoma
10. Intensive 1,3-bis(2-chloroethyl)-1-nitrosourea (BCNU) monochemotherapy and autologous marrow transplantation for malignant glioma
11. High-dose of carmustine with autologous bone marrow transplantation for the adjuvant treatment of high-grade gliomas of the central nervous system
12. Post-operative high dose BCNU followed by autologous bone marrow transplantation and radiotherapy in newly diagnostic high-grade astrocytomas
13. High-dose BCNU and autologous progenitor cell transplantation given with intra-arterial cisplatin and simultaneous radiotherapy in the treatment of high-grade gliomas: Benefit for selected patients
14. High-dose thiotepa with autologous bone marrow transplantation (ABMT) and localized radiotherapy for patients with astrocytoma grado III/IV (glioma): A promising approach
15. High dose BCNU followed by autologous bone marrow infusion in glioblastoma multiforme
16. Autologous bone marrow transplantation: Host effects of high-dose BCNU
17. Megadose chemotherapy with bone marrow rescue
18. High dose BCNU with autologous bone marrow rescue for recurrent glioblastoma multiforme
19. High dose BCNU with autologous bone marrow rescue for recurrent malignant gliomas
20. Phase II treatment of central nervous system gliomas with high-dose etoposide and autologous bone marrow transplantation
21. Intensive chemotherapy with autologous bone marrow rescue for recurrent malignant gliomas
22. Myocardial ischemia associated with high-dose carmustine infusion
23. Acute neurologic dysfunction after high-dose etoposide therapy for malignant glioma
24. Fluctuation of serum phentoin concentrations during autologous bone marrow transplantation for primary central nervous system tumors